The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., Garren, N., Mackey, M., Butman, J. A., Camphausen, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3055 · Cited by 1,577
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Marcello, J., Reardon, D. A., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2440 · Cited by 1,394
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
Sanai, N., & Berger, M. S. (2008) · Neurosurgery · doi:10.1227/01.neu.0000318159.21731.cf · Cited by 1,328
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
Giese, A., Bjerkvig, R., Berens, M. E., & Westphal, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.063 · Cited by 1,200
Hartmann, C., Meyer, J., Balss, J., Capper, D., Mueller, W., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163
Wick, W., Platten, M., Meisner, C., Felsberg, J., Tabatabai, G., Simon, M., Nikkhah, G., Papsdorf, K., Steinbach, J. P., Sabel, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70164-x · Cited by 1,135
Stummer, W., Reulen, H.-J., Meinel, T., Pichlmeier, U., Schumacher, W., Tonn, J.-C., Rohde, V., Oppel, F., Turowski, B., Woiciechowsky, C., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000317304.31579.17 · Cited by 1,035
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
Watanabe, T., Nobusawa, S., Kleihues, P., & Ohgaki, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080958 · Cited by 1,027
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Sanson, M., Marie, Y., Paris, S., Idbaih, A., Laffaire, J., Ducray, F., El Hallani, S., Boisselier, B., Mokhtari, K., Hoang-Xuan, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9832 · Cited by 1,008
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975
Yung, W. K. A., Albright, R. E., Olson, J., Fredericks, R., Fink, K., Prados, M. D., Brada, M., Spence, A., Hohl, R. J., Shapiro, W., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1316 · Cited by 929
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
van Breemen, M. S., Wilms, E. B., & Vecht, C. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70103-5 · Cited by 913
Roa, W., Brasher, P. M. A., Bauman, G., Anthes, M., Bruera, E., Chan, A., Fisher, B., Fulton, D., Gulavita, S., Hao, C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.082 · Cited by 904
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Radiotherapy for Glioblastoma in the Elderly
Keime-Guibert, F., Chinot, O., Taillandier, L., Cartalat-Carel, S., Frenay, M., Kantor, G., Guillamo, J.-S., Jadaud, E., Colin, P., Bondiau, P.-Y., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065901 · Cited by 792
Yung, W. K. A., Prados, M. D., Yaya-Tur, R., Rosenfeld, S. S., Brada, M., Friedman, H. S., Albright, R., Olson, J., Chang, S. M., O'Neill, A. M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2762 · Cited by 761
van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J. B., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., Sipos, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6078 · Cited by 748
Cairncross, G., Berkey, B., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L., Laperierre, N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3414 · Cited by 728
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
Iyer, G., Hanrahan, A. J., Milowsky, M. I., Al-Ahmadie, H., Scott, S. N., Janakiraman, M., Pirun, M., Sander, C., Socci, N. D., Ostrovnaya, I., et al. (2012) · Science · doi:10.1126/science.1226344 · Cited by 690
Weller, M., Felsberg, J., Hartmann, C., Berger, H., Steinbach, J. P., Schramm, J., Westphal, M., Schackert, G., Simon, M., Tonn, J. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0805 · Cited by 614
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
Bettegowda, C., Agrawal, N., Jiao, Y., Sausen, M., Wood, L. D., Hruban, R. H., Rodriguez, F. J., Cahill, D. P., McLendon, R., Riggins, G., et al. (2011) · Science · doi:10.1126/science.1210557 · Cited by 553
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
Houillier, C., Wang, X., Kaloshi, G., Mokhtari, K., Guillevin, R., Laffaire, J., Paris, S., Boisselier, B., Idbaih, A., Laigle-Donadey, F., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f96282 · Cited by 535
Wick, W., Puduvalli, V. K., Chamberlain, M. C., van den Bent, M. J., Carpentier, A. F., Cher, L. M., Mason, W., Weller, M., Hong, S., Musib, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2595 · Cited by 525
Rivera, A. L., Pelloski, C. E., Gilbert, M. R., Colman, H., De La Cruz, C., Sulman, E. P., Bekele, B. N., & Aldape, K. D. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop020 · Cited by 434
van den Bent, M. J., Dubbink, H. J., Marie, Y., Brandes, A. A., Taphoorn, M. J. B., Wesseling, P., Frenay, M., Tijssen, C. C., Lacombe, D., Idbaih, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2902 · Cited by 381
Pseudoprogression and pseudoresponse in the treatment of gliomas
Brandsma, D., & van den Bent, M. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328332363e · Cited by 378
Prados, M. D., Chang, S. M., Butowski, N., DeBoer, R., Parvataneni, R., Carliner, H., Kabuubi, P., Ayers-Ringler, J., Rabbitt, J., Page, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9639 · Cited by 378
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
Park, J. K., Hodges, T., Arko, L., Shen, M., Dello Iacono, D., McNabb, A., Olsen Bailey, N., Kreisl, T. N., Iwamoto, F. M., Sul, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0582 · Cited by 359
Stupp, R., Tonn, J.-C., Brada, M., & Pentheroudakis, G. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq187 · Cited by 348
Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme
Barker, F. G., Chang, S. M., Gutin, P. H., Malec, M. K., McDermott, M. W., Prados, M. D., & Wilson, C. B. (1998) · Neurosurgery · doi:10.1097/00006123-199804000-00013 · Cited by 330
Glioma Stem Cells: A Midterm Exam
Stiles, C. D., & Rowitch, D. H. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.031 · Cited by 330
Quinn, J. A., Jiang, S. X., Reardon, D. A., Desjardins, A., Vredenburgh, J. J., Rich, J. N., Gururangan, S., Friedman, A. H., Bigner, D. D., Sampson, J. H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8417 · Cited by 316
Chang, S. M., Parney, I. F., Mcdermott, M., Barker, F. G., Schmidt, M. H., Huang, W., Laws, E. R., Lillehei, K. O., Bernstein, M., Brem, H., et al. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.6.1175 · Cited by 310
Yip, S., Butterfield, Y. S., Morozova, O., Chittaranjan, S., Blough, M. D., An, J., Birol, I., Chesnelong, C., Chiu, R., Chuah, E., et al. (2012) · The Journal of Pathology · doi:10.1002/path.2995 · Cited by 307
Kuhnt, D., Becker, A., Ganslandt, O., Bauer, M., Buchfelder, M., & Nimsky, C. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor133 · Cited by 300
McGirt, M. J., Than, K. D., Weingart, J. D., Chaichana, K. L., Attenello, F. J., Olivi, A., Laterra, J., Kleinberg, L. R., Grossman, S. A., Brem, H., et al. (2009) · Journal of Neurosurgery · doi:10.3171/2008.5.17557 · Cited by 299
Gaspar, L. E., Fisher, B. J., Macdonald, D. R., Leber, D. V., Halperin, E. C., Schold, S. C., & Cairncross, J. G. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91021-e · Cited by 295
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
Weller, M., Gorlia, T., Cairncross, J. G., van den Bent, M. J., Mason, W., Belanger, K., Brandes, A. A., Bogdahn, U., Macdonald, D. R., Forsyth, P., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822f02e1 · Cited by 290
Molecular diagnostics of gliomas: state of the art
Riemenschneider, M. J., Jeuken, J. W. M., Wesseling, P., & Reifenberger, G. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0736-4 · Cited by 283
Recurrent glioblastoma multiforme: a review of natural history and management options
Hou, L. C., Veeravagu, A., Hsu, A. R., & Tse, V. C. K. (2006) · Neurosurgical Focus · doi:10.3171/foc.2006.20.4.2 · Cited by 275
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
Labussière, M., Idbaih, A., Wang, X.-W., Marie, Y., Boisselier, B., Falet, C., Paris, S., Laffaire, J., Carpentier, C., Crinière, E., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e1cf3a · Cited by 260
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
Neyns, B., Sadones, J., Joosens, E., Bouttens, F., Verbeke, L., Baurain, J.-F., D'Hondt, L., Strauven, T., Chaskis, C., In't Veld, P., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp032 · Cited by 250
Molecular subclassification of diffuse gliomas: Seeing order in the chaos
Huse, J. T., Phillips, H. S., & Brennan, C. W. (2011) · Glia · doi:10.1002/glia.21165 · Cited by 233
Brandes, A. A., Tosoni, A., Cavallo, G., Bertorelle, R., Gioia, V, Franceschi, E., Biscuola, M., Blatt, V, Crinò, L., & Ermani, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603376 · Cited by 228
Raymond, E., Brandes, A. A., Dittrich, C., Fumoleau, P., Coudert, B., Clement, P. M. J., Frenay, M., Rampling, R., Stupp, R., Kros, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9235 · Cited by 227
Helseth, R., Helseth, E., Johannesen, T. B., Langberg, C. W., Lote, K., Rønning, P., Scheie, D., Vik, A., & Meling, T. R. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01350.x · Cited by 215
Pérez-Larraya, J. G., Ducray, F., Chinot, O., Catry-Thomas, I., Taillandier, L., Guillamo, J.-S., Campello, C., Monjour, A., Cartalat-Carel, S., Barrie, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8086 · Cited by 212
Franceschi, E., Cavallo, G., Lonardi, S., Magrini, E., Tosoni, A., Grosso, D., Scopece, L., Blatt, V, Urbini, B., Pession, A., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603669 · Cited by 211
Felsberg, J., Rapp, M., Loeser, S., Fimmers, R., Stummer, W., Goeppert, M., Steiger, H.-J., Friedensdorf, B., Reifenberger, G., & Sabel, M. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2801 · Cited by 203
Medical management of patients with brain tumors
Wen, P. Y., Schiff, D., Kesari, S., Drappatz, J., Gigas, D. C., & Doherty, L. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9193-2 · Cited by 191
Stummer, W., van den Bent, M. J., & Westphal, M. (2011) · Acta Neurochirurgica · doi:10.1007/s00701-011-1001-x · Cited by 188
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
Lassman, A. B., Iwamoto, F. M., Cloughesy, T. F., Aldape, K. D., Rivera, A. L., Eichler, A. F., Louis, D. N., Paleologos, N. A., Fisher, B. J., Ashby, L. S., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor040 · Cited by 176
Oszvald, Á., Güresir, E., Setzer, M., Vatter, H., Senft, C., Seifert, V., & Franz, K. (2012) · Journal of Neurosurgery · doi:10.3171/2011.8.jns102114 · Cited by 175
Bobustuc, G. C., Baker, C. H., Limaye, A., Jenkins, W. D., Pearl, G. S., Avgeropoulos, N. G., & Konduri, S. D. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq044 · Cited by 156
Chaichana, K. L., Garzón-Muvdi, T., Park, P., WEINGART, J. D., Olivi, A., Bennett, R., Brem, H., & Quiñones‐Hinojosa, A. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1242-6 · Cited by 149
Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival
Ewelt, C., Göppert, M., Rapp, M., Steiger, H., Stummer, W., & Sabel, M. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0429-9 · Cited by 146
Romanelli, P., Conti, A., Pontoriero, A., et al. (2009) · Neurosurgical FOCUS · doi:10.3171/2009.9.focus09187 · Cited by 139
Yan, W., Zhang, W., You, G., Bao, Z., Wang, Y., Liu, Y., Kang, C., You, Y., Wang, L., & Jiang, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030339 · Cited by 135
Self-citationCombined 1p/19q Loss in Oligodendroglial Tumors: Predictive or Prognostic Biomarker?
The German Glioma Network, Weller, M., Berger, H., Hartmann, C. J., Schramm, J., Westphal, M., Simon, M., Goldbrunner, R., Krex, D., Steinbach, J. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0573 · Cited by 129
Targeting apoptosis pathways in cancer stem cells
Signore, M., Ricci‐Vitiani, L., & Maria, R. D. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.013 · Cited by 127
Intussusceptive microvascular growth in tumors
Ribatti, D., & Djonov, V. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.040 · Cited by 124
Wedge, S. R., Porteous, J. K., & Newlands, E. S. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.485 · Cited by 123
Clarke, J. L., Ennis, M. M., Yung, W. K. A., Chang, S., Wen, P. Y., Cloughesy, T. F., DeAngelis, L. M., Robins, H. I., Lieberman, F. S., Fine, H. A., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor110 · Cited by 120
Molecular pathogenesis of oligodendroglial tumors
Jeuken, J. W. M., von Deimling, A., & Wesseling, P. (2004) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-2748-1 · Cited by 119
Brandes, A. A., Basso, U., Reni, M., Vastola, F., Tosoni, A., Cavallo, G., Scopece, L., Ferreri, A. J. M., Panucci, M. G., Monfardini, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.019 · Cited by 117
Survey of treatment recommendations for anaplastic oligodendroglioma
Abrey, L. E., Louis, D. N., Paleologos, N. A., Lassman, A. B., Raizer, J. J., Mason, W. P., Finlay, J. L., Macdonald, D. R., DeAngelis, L. M., & Cairncross, J. G. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-002 · Cited by 108
Rechallenge with temozolomide in patients with recurrent gliomas
Wick, A., Pascher, C., Wick, W., Jauch, T., Weller, M., Bogdahn, U., & Hau, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5006-9 · Cited by 108
van den Bent, M. J., Gravendeel, L. A. M., Gorlia, T., Kros, J. M., Lapre, L., Wesseling, P., Teepen, J. L. J. M., Idbaïh, A., Sanson, M., Smitt, P. A. E. S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1274 · Cited by 108
Pérez‐Larraya, J. G., Lahutte, M., Petrirena, G. J., Reyes-Botero, G., González-Aguilar, A., Houillier, C., Guillevin, R., Sanson, M., Hoang‐Xuan, K., & Delattre, J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos070 · Cited by 106
Nieder, C., Astner, S. T., Mehta, M. P., Grosu, A., & Molls, M. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815e3fdc · Cited by 104
The pathogenesis of tumor-related epilepsy and its implications for clinical treatment
You, G., Sha, Z., & Jiang, T. (2012) · Seizure · doi:10.1016/j.seizure.2011.12.016 · Cited by 100
Self-citationErnst‐Stecken, A., Ganslandt, O., Lambrecht, U., Sauer, R., & Grabenbauer, G. G. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9231-0 · Cited by 93
Kouwenhoven, M. C. M., Gorlia, T., Kros, J. M., Ibdaih, A., Brandes, A. A., Bromberg, J. E. C., Mokhtari, K., van Duinen, S. G., Teepen, J. L. J. M., Wesseling, P., et al. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-011 · Cited by 89
Sciuscio, D., Diserens, A., Dommelen, K. V., Martinet, D., Jones, G., Janzer, R.-C., Pollo, C., Hamou, M., Kaina, B., Stupp, R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1931 · Cited by 84
Glioblastoma cancer stem cells – From concept to clinical application
Stopschinski, B. E., Beier, C. P., & Beier, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.033 · Cited by 84
Targeting apoptosis pathways in glioblastoma
Eisele, G., & Weller, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.12.012 · Cited by 83
Temozolomide in Combination With Irinotecan for Treatment of Recurrent Malignant Glioma
Gruber, M. L., & Buster, W. P. (2004) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000045852.88461.80 · Cited by 80
Olson, R. A., Brastianos, P. K., & Palma, D. A. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0594-5 · Cited by 80
Recent Surgical Management of Gliomas
Sanai, N., & Berger, M. S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3146-6_2 · Cited by 73
Cao, J. Q., Fisher, B. J., Bauman, G. S., Megyesi, J. F., Watling, C., & Macdonald, D. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0766-3 · Cited by 71
Hypofractionated reirradiation for recurrent malignant glioma
Henke, G., Paulsen, F., Steinbach, J. P., Ganswindt, U., Isijanov, H., Kortmann, R., Bamberg, M., & Belka, C. (2009) · Strahlentherapie und Onkologie · doi:10.1007/s00066-009-1969-9 · Cited by 70
Wang, Y., Li, S., Chen, L., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor232 · Cited by 70
Self-citationZhang, W., Yan, W., You, G., Bao, Z., Wang, Y., Liu, Y., You, Y., & Jiang, T. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.033 · Cited by 65
Self-citationGlioblastoma: the past, the present, and the future.
Wilson, C. B. (1992) · PubMed · Cited by 64
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Panageas, K. S., IWAMOTO, F. M., Cloughesy, T. F., Aldape, K., Rivera, A. L., Eichler, A. F., Louis, D. N., Paleologos, N. A., Fisher, B. J., Ashby, L., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos065 · Cited by 57
Brell, M., Ibáñez, J., & Tortosa, A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-35 · Cited by 50
Li, S., Yan, C., Huang, L. F., Qiu, X., Wang, Z., & Jiang, T. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor185 · Cited by 39
Self-citationIrinotecan and bevacizumab in recurrent glioblastoma multiforme
Jakobsen, J. N., Hasselbalch, B., Stockhausen, M., Lassen, U., & Poulsen, H. S. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.566558 · Cited by 39
DNA methylation in thoracic neoplasms
Chen, C., Yin, N., Yin, B., & Lu, Q. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.017 · Cited by 38
Oncogene addiction in gliomas: Implications for molecular targeted therapy
Yan, W., Zhang, W., & Jiang, T. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-58 · Cited by 37
Self-citationIs protracted low-dose temozolomide feasible in glioma patients?
Tosoni, A., Cavallo, G., Ermani, M., Scopece, L., Franceschi, E., Ghimenton, C., Gardiman, M. P., Pasetto, L. M., Blatt, V., & Brandes, A. A. (2006) · Neurology · doi:10.1212/01.wnl.0000196465.83423.ec · Cited by 37
Jin, X., Jin, X. J., Sohn, Y.-W., Yin, J., Kim, S.-H., Joshi, K., Nam, D., Nakano, I., & Kim, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.09.005 · Cited by 35
Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT
Lee, J., Ku, T., Yu, H., Chong, K., Ryu, S., Choi, K., & Choi, C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.014 · Cited by 35
Lee, J., Lee, J., Yu, H., Choi, K., & Choi, C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.026 · Cited by 35
Association BetweenMGMTPromoter Hypermethylation and p53 Mutation in Glioblastoma
Shamsara, J., Sharif, S., Afsharnezhad, S., Lotfi, M., Raziee, H., Ghaffarzadegan, K., Moradi, A., Rahighi, S., & Behravan, J. (2009) · Cancer Investigation · doi:10.1080/07357900902783211 · Cited by 29
Moliterno, J. A., Patel, T., & Piepmeier, J. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3183243f6e3 · Cited by 21
Classification and management of anaplastic gliomas
Wick, W., & Weller, M. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283329ce7 · Cited by 18
Surgical strategies for glioma involving language areas
ZHANG, Z., Jiang, T., Xie, J., Liu, F., Li, S., Qiao, H., & Wang, Z. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200809020-00009 · Cited by 12
Self-citation
Cited by
Bao, Z.-S., Chen, H.-M., Yang, M.-Y., Zhang, C.-B., Yu, K., Ye, W.-L., Hu, B.-Q., Yan, W., Zhang, W., Akers, J., et al. (2014) · Genome Research · doi:10.1101/gr.165126.113 · Cited by 409
Self-citation
Metadata
- Authors
- Wang, Y., & Jiang, T.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 331
- Issue
- 2
- Pages
- 139-146
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2008721015
- Cited by
- 260
- References
- 108
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.